Zhao Peng, Sun Huaxia
Department of Neurology, The Second Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, China.
Department of Neurology, Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong Province, China.
Brain Behav. 2025 Mar;15(3):e70389. doi: 10.1002/brb3.70389.
Stroke remains a leading cause of death and long-term disability in China. Rehabilitation is known to be an effective intervention for reducing disability among stroke survivors. This study seeks to quantify the rehabilitation needs of stroke patients in China by analyzing prevalence and years lived with disability (YLDs).
To assess rehabilitation needs, we first estimated the prevalence and YLDs among stroke patients in China using data from the Global Burden of Disease Study 2019. The WHO Rehabilitation Need Estimator was then applied to these estimates to derive the rehabilitation requirements.
Our study reveals a substantial need for stroke rehabilitation services in China in 2019. An estimated 25.0 million stroke patients (95% uncertainty interval [UI] 22.0-28.0) could benefit from these services, accounting for 6.1 million years lived with disability (YLDs) [4.3-7.8]. This burden is disproportionately distributed between genders, with males experiencing 11.0 [9.5-12.0] million prevalent cases and 2.5 [1.8-3.2] million YLDs, compared to females with 14.0 [12.0-16.0] million cases and 3.6 [2.5-4.8] million YLDs. Worryingly, the age-standardized prevalence of stroke in China has increased by 15.2% since 1990, rising from 11.2 per 1000 (95UI, 10.1-12.5) to 12.9 per 1000 (95UI, 11.5-14.4). Similarly, the age-standardized YLD rate has grown by 15.8%, from 2.72 per 1000 (95UI, 1.94-3.49) to 3.15 per 1000 (95UI, 2.21-4.48). This upward trend in China contrasts sharply with the global picture, where age-standardized prevalence and YLD rates have decreased by 6.2% and 4.8%, respectively.
These findings demonstrate a critical need for expanded access to rehabilitation services within China's stroke care system. To enhance patient outcomes and address this growing need, increased investment in stroke rehabilitation infrastructure, training, and research is essential.
在中国,中风仍然是导致死亡和长期残疾的主要原因。康复治疗是减少中风幸存者残疾的有效干预措施。本研究旨在通过分析患病率和残疾生存年数(YLDs)来量化中国中风患者的康复需求。
为评估康复需求,我们首先利用《2019年全球疾病负担研究》的数据估算了中国中风患者的患病率和YLDs。然后将世界卫生组织康复需求估算器应用于这些估算值,以得出康复需求。
我们的研究表明,2019年中国对中风康复服务有巨大需求。估计有2500万中风患者(95%不确定区间[UI]为2200万-2800万)可从这些服务中受益,占610万残疾生存年数(YLDs)[430万-780万]。这种负担在性别间分布不均,男性有1100万[950万-1200万]例患病率和250万[180万-320万]例YLDs,而女性有1400万[1200万-1600万]例和360万[250万-480万]例YLDs。令人担忧的是,自1990年以来,中国中风的年龄标准化患病率上升了15.2%,从每1000人11.2例(95%UI,10.1-12.5)升至每1000人12.9例(95%UI,11.5-14.4)。同样,年龄标准化YLD率增长了15.8%,从每1000人2.72例(95%UI,1.94-3.49)升至每1000人3.15例(95%UI,2.21-4.48)。中国的这一上升趋势与全球情况形成鲜明对比,全球年龄标准化患病率和YLD率分别下降了6.2%和4.8%。
这些发现表明,在中国中风护理系统中,迫切需要扩大康复服务的可及性。为提高患者治疗效果并满足这一日益增长的需求,加大对中风康复基础设施、培训和研究的投资至关重要。